Robert N J, Dalton W S, Osborne C K, Abeloff M
Southwest Oncology Group, New England Medical Center, Boston, Mass.
Horm Res. 1989;32 Suppl 1:221-2. doi: 10.1159/000181351.
The basis and design of a trial that will compare surgical oophorectomy with the LHRH analogue, Zoladex, in the treatment of premenopausal women with advanced, oestrogen receptor-positive or progesterone receptor-positive breast cancer, is described.
本文描述了一项试验的基础和设计,该试验将比较手术卵巢切除术与促性腺激素释放激素类似物(诺雷德)在治疗绝经前、雌激素受体阳性或孕激素受体阳性的晚期乳腺癌女性中的效果。